Live Breaking News & Updates on Corneal Endothelial

Stay updated with breaking news from Corneal endothelial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial

SEATTLE & CAMBRIDGE, Mass. & TOKYO, March 28, 2024 Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has dosed the first Canadian subject in its Phase 1 / 2 clinical trial (ABA-1, CLARA) of AURN001, a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction. ....

United Kingdom , United States , Michele Gray , Judith Mcgarry , Michael Goldstein , Prix Galien , Beth Keshishian , Allogeneic Cell Therapy , Corneal Edema Secondary , Corneal Endothelial , Aurion Biotech , Chief Medical Officer , Flyingl Partners , Falcon Vision ,